You are viewing the site in preview mode

Skip to main content

Advertisement

Table 6 Factors associated with higher out-of-pocket patient payments in a regression model (n=367) a

From: Costs associated with febrile neutropenia in solid tumor and lymphoma patients – an observational study in Singapore

Variablesb Unstandardized coefficient (B) 95% CI for B Standard error Standardized coefficient (B) p valuec
Lower bound Upper bound
Length of stay 0.054 0.049 0.060 0.003 0.614 < 0.001
Time to ANC recovery 0.004 -0.004 0.013 0.004 0.031 0.320
ANC at presentation -0.003 -0.085 0.080 0.042 -0.002 0.948
MASCC score < 21 0.019 -0.033 0.072 0.027 0.022 0.473
Lymphoma 0.067 0.012 0.121 0.028 0.080 0.017
Male gender 0.017 -0.027 0.060 0.022 0.024 0.452
Severe sepsis 0.081 0.020 0.142 0.031 0.085 0.009
Inpatient referral 0.013 -0.048 0.074 0.031 0.013 0.683
18-40 year age group 0.082 0.019 0.144 0.032 0.078 0.011
Therapeutic GCSF treatment 0.101 0.041 0.161 0.030 0.100 0.001
Private Ward (Class A or B1) 0.408 0.359 0.457 0.025 0.499 < 0.001
  1. a. Adjusted R2 = 0.691, p < 0.001; b. Only clinically relevant variables that were statistically significant at p value of 0.05 in the univariate analysis were included in the regression model; c. Bolded p values are statistically significant; ANC = absolute neutrophil count; GCSF = granulocyte colony-stimulating factor; MASCC = Multinational Association of Supportive Care in Cancer.